Search

Your search keyword '"M. Dallago"' showing total 89 results

Search Constraints

Start Over You searched for: Author "M. Dallago" Remove constraint Author: "M. Dallago"
89 results on '"M. Dallago"'

Search Results

51. OTIMIZAÇÃO DO PROCESSO DE PRODUÇÃO DE OLEATO DE ETILA VIA CATALISE ENZIMÁTICA IMOBILIZADA EM SITU EM POLIURETANO EM SISTEMA LIVRE DE SOLVENTE

52. ESTUDO PRÉVIO PARA TRANSESTERIFICAÇÃO ENZIMÁTICA DE ÓLEOS VEGETAIS EM MEIO ORGÂNICO

55. ESTABILIDADE OPERACIONAL DA ENZIMA COMERCIAL Candida antarctica B (CAL B) IMOBILIZADA EM MATRIZ HIDROFÓBICA

56. EFEITO DA ESTABILIDADE DE ESTOCAGEM DA LIPASE COMERCIAL DE Candida antarctica B (CALB) NA FORMA LIVRE E IMOBILIZADA POR CONFINAMENTO EM SUPORTE DE POLIURETANO

57. ESTERIFICATION OF ACETIC ACID WITH ALCOHOL ISOAMYL IN THE PRESENCE OF ENZYMATIC CATALYST.

58. Characterization of Cu/CeO2/Al2O3 catalysts by temperature programmed reduction and activity for CO oxidation

59. Cardiac Arrest and Sudden Death in Competitive Athletes with Arrhythmogenic Right Ventricular Dysplasia

60. Purification of inulinases by changing the ionic strength of the medium and precipitation with alcohols

61. Immobilization of lipase on mesoporous molecular sieve MCM-48 obtained using ionic solid as a structure director and esterification reaction on solvent-free

62. OPTIMIZATION OF SOLVENT-FREE GERANYL BUTANOATE PRODUCTION USING NOVOZYME 435 AND HOMEMADE POLYURETHANE IMMOBILIZED NOVOZYME NZL-102-LYO-HQ AS CATALYSTS

63. Electropharmacological testing by transoesophageal atrial pacing in inducible supraventricular tachyarrhythmias

64. Risk Identification in Arrhythmic Athletes with Fatal or Resuscitated Cardiac Arrest

65. Life-threatening tachyarrhythmias in athletes

66. Electropharmacological testing by transoesophageal atrial pacing in inducible supraventricular tachyarrhythmias. A good approach for selection of long-term anti-arrhythmic therapy

67. [Supraventricular reentry tachycardia and athletic fitness]

68. [Cardiac rhythm in athletes: a Holter study of top level and ex-professional football players]

69. Even top level «éliteå athletes may complain of serious arrhythmic manifestations

70. INCIDENCE AND CLINICAL FEATURES OF THE RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) WITH OR WITHOUT BARE METAL STENT: A SINGLE CENTRE EXPERIENCE.

71. Effect of Plate Type on Tibial Plateau Levelling and Medialization Osteotomy for Treatment of Cranial Cruciate Ligament Rupture and Concomitant Medial Patellar Luxation in Small Breed Dogs: An In Vitro Study.

72. Implementation of a Night Service of Helicopter Transportation to Reduce the Time to Revascularization in STEMI Patients in a Mountainous Region: Impact on Outcomes.

73. How to keep the cath-lab of a COVID-free hub center during the pandemic in a hub and spoke cardiology network: a single center's experience.

74. Additively manufactured Ti-6Al-4V thin struts via laser powder bed fusion: Effect of building orientation on geometrical accuracy and mechanical properties.

75. Sex differences in clinical and angiographic characteristics in spontaneous coronary artery dissection.

76. Transoral approach for mandibular and sublingual sialoadenectomy in a cat.

77. [Periprocedural management of anticoagulation therapy and in-hospital outcomes in patients with warfarin indication undergoing percutaneous coronary intervention. Data from the WAR-STENT registry].

78. [Risk assessment and early predictors of survival after out-of-hospital cardiac arrest in the province of Trento, Italy].

79. A patient-specific mass-spring model for biomechanical simulation of aortic root tissue during transcatheter aortic valve implantation.

80. Fatigue and biological properties of Ti-6Al-4V ELI cellular structures with variously arranged cubic cells made by selective laser melting.

81. Twelve-month outcome of patients with an established indication for oral anticoagulation undergoing coronary artery stenting and stratified by the baseline risk of bleeding: Insights from the Warfarin and Coronary Stenting (War-Stent) Registry.

82. Does pre-existing aortic regurgitation protect from death in patients who develop paravalvular leak after TAVI?

83. Atrial fibrillation in elite athletes.

84. Cardiac arrest and sudden death in competitive athletes with arrhythmogenic right ventricular dysplasia.

85. Life-threatening tachyarrhythmias in athletes.

86. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing.

87. Electropharmacological testing by transoesophageal atrial pacing in inducible supraventricular tachyarrhythmias. A good approach for selection of long-term anti-arrhythmic therapy.

88. [Supraventricular reentry tachycardia and athletic fitness].

89. [Cardiac rhythm in athletes: a Holter study of top level and ex-professional football players].

Catalog

Books, media, physical & digital resources